Patients in Japan seek stable supply of medical goods as war concerns loom
Shortages of naphtha — an ingredient used to make plastic — has hospitals and patients in Japan worried…
How bad will Europe’s energy crisis get? – POLITICO
“Markets are now grappling with a scenario long discussed in theory but rarely thought of as a legitimate…
Venture Funding To City’s Startups Hits All-Time High
At the height of the pandemic and the global shift to remote work, tech founders and investors alike…
Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
New nanoparticle system boosts scalable production of therapeutic exosomes
Researchers from Xi’an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to…
2 Unstoppable Artificial Intelligence (AI) Stocks to Buy Right Now for Less Than $1,000
The rapid adoption of artificial intelligence (AI) is creating generational wealth-building opportunities for investors. Demand for the chips…
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
Last Updated: March 17, 2026 at 6:27 p.m. ETFirst Published: March 17, 2026 at 2:28 p.m. ET In a surprising…
Samsung turns to cheaper Chinese displays for Galaxy S26 FE and A57 as memory prices bite
Samsung is going downmarket with its phone OLED screens, eschewing its own display department production and replacing it…
FG urges women to seize trade opportunities in Nigeria
The Federal Government has urged women to take advantage of trade and entrepreneurship opportunities to strengthen Nigeria’s economy.…
Cambridge’s LED breakthrough reinvents drug synthesis
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light…
Deepa Kohli on Building a Modern Sourcing Model and Championing Women Entrepreneurs
Popular Posts
Mar 07, 2026 | 11 hours ago Mar 07, 2026 | 15 hours ago Mar…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…